A clear example is given by [11C]erlotinib, where both SUV and TBR, derived from static scans, do not show significant differences between tumours with and tumours without mutated epidermal growth factor receptors (EGFR), in contrast to the volume of distribution (VT) derived from dynamic scans [11]. Here, EGFR is linked to neoplasm.